{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:59:48Z","timestamp":1790747988345,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jaut.2010.10.003","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T04:45:57Z","timestamp":1289450757000},"page":"33-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Novel autoantibody markers for early and seronegative rheumatoid arthritis"],"prefix":"10.1016","volume":"36","author":[{"given":"Klaartje","family":"Somers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Rummens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Stinissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaut.2010.10.003_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.jaut.2010.10.003_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jaut.2010.10.003_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.jaut.2010.10.003_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaut.2010.10.003_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2010.10.003_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","article-title":"Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis","volume":"1143","author":"van Venrooij","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.jaut.2010.10.003_bib8","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/art.22716","article-title":"Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaut.2010.10.003_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2384","article-title":"Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets","volume":"10","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2010.10.003_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-008-0028-3","article-title":"Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis","volume":"10","author":"Crow","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.jaut.2010.10.003_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/ard.2007.085787","article-title":"Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies","volume":"68","author":"Keystone","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2010.10.003_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1749-6632.2009.04668.x","article-title":"Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects","volume":"1173","author":"Quartuccio","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.jaut.2010.10.003_bib14","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.4049\/jimmunol.180.6.3957","article-title":"Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates","volume":"180","author":"Somers","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2010.10.003_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2009.04654.x","article-title":"Optimisation of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis","volume":"1173","author":"Somers","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2010.10.003_bib16","series-title":"Autoantigens, autoantibodies, autoimmunity","article-title":"Novel autoantibody targets in seronegative rheumatoid arthritis","author":"Somers","year":"2009"},{"key":"10.1016\/j.jaut.2010.10.003_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1398.043","article-title":"Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure","volume":"1109","author":"Govarts","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaut.2005.09.023","article-title":"Profiling the autoantibody repertoire by serological antigen selection","volume":"25","author":"Somers","year":"2005","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.jaut.2010.10.003_bib19","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.169.5.2772","article-title":"A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library","volume":"169","author":"Somers","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jaut.2010.10.003_bib20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJMoa051931","article-title":"Autoantibody signatures in prostate cancer","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaut.2010.10.003_bib21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.170.4.1894","article-title":"Locus-specific constitutive and cytokine-induced HLA class I gene expression","volume":"170","author":"Johnson","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jaut.2010.10.003_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-1229(90)90102-V","article-title":"Anti-class II beta-chain antibodies in the serum and synovial fluid of rheumatoid arthritis patients","volume":"55","author":"Marnell","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.jaut.2010.10.003_bib23","first-page":"30","article-title":"Lymphocytotoxic antibodies in Israeli patients with rheumatoid arthritis","volume":"33","author":"Livneh","year":"1997","journal-title":"Isr J Med Sci"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2010.10.003_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08820139809070887","article-title":"Relationship between HLA antigens and infectious agents in contributing towards the development of Graves\u2019 disease","volume":"27","author":"Kraemer","year":"1998","journal-title":"Immunol Invest"},{"issue":"10","key":"10.1016\/j.jaut.2010.10.003_bib25","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.4049\/jimmunol.140.10.3489","article-title":"Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies","volume":"140","author":"Raybourne","year":"1988","journal-title":"J Immunol"},{"issue":"5473","key":"10.1016\/j.jaut.2010.10.003_bib26","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.288.5473.2045","article-title":"Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6","volume":"288","author":"Volarevic","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jaut.2010.10.003_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","article-title":"Ribosomal protein S6 phosphorylation: from protein synthesis to cell size","volume":"31","author":"Ruvinsky","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.jaut.2010.10.003_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/bbrc.1997.6865","article-title":"Expression, nuclear localization and interactions of human MCM\/P1 proteins","volume":"236","author":"Tsuruga","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2010.10.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.10.011","article-title":"The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases","volume":"340","author":"Routsias","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.jaut.2010.10.003_bib30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaut.2010.10.003_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.ejhg.5201827","article-title":"Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE","volume":"15","author":"Graham","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.jaut.2010.10.003_bib32","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jaut.2010.10.003_bib33","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jaut.2010.10.003_bib34","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaut.2010.10.003_bib35","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaut.2010.10.003_bib36","first-page":"3842","article-title":"Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein","volume":"11","author":"Pogue-Geile","year":"1991","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.jaut.2010.10.003_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000133647","article-title":"The human gene for nuclear protein BM28 (CDCL1), a new member of the early S-phase family of proteins, maps to chromosome band 3q21","volume":"65","author":"Mincheva","year":"1994","journal-title":"Cytogenet Cell Genet"},{"issue":"6","key":"10.1016\/j.jaut.2010.10.003_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","article-title":"Synovial fibroblasts: key players in rheumatoid arthritis","volume":"45","author":"Huber","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(21)00462-2","article-title":"Oncogenes in rheumatoid arthritis","volume":"21","author":"Muller-Ladner","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.jaut.2010.10.003_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.23148","article-title":"Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis","volume":"58","author":"van Oosterhout","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaut.2010.10.003_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ard.2008.096917","article-title":"New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA","volume":"68","author":"Auger","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.jaut.2010.10.003_bib42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","article-title":"Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins","volume":"53","author":"Bizzaro","year":"2007","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.jaut.2010.10.003_bib43","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.24720","article-title":"Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value","volume":"60","author":"Levesque","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/ar297","article-title":"B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection","volume":"3","author":"Voswinkel","year":"2001","journal-title":"Arthritis Res"},{"issue":"3","key":"10.1016\/j.jaut.2010.10.003_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/art.23266","article-title":"Spondylarthritis in the absence of B lymphocytes","volume":"58","author":"Baeten","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaut.2010.10.003_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/berh.2002.0263","article-title":"Seronegative spondyloarthritides","volume":"16","author":"Olivieri","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jaut.2010.10.003_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein\u2013Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"Niller","year":"2008","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaut.2010.10.003_bib48","first-page":"259","article-title":"Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes","volume":"25","author":"Rashid","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"13","key":"10.1016\/j.jaut.2010.10.003_bib49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/0961203309351081","article-title":"Infections, vaccines and autoimmunity","volume":"18","author":"Shoenfeld","year":"2009","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.jaut.2010.10.003_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:02:46Z","timestamp":1760256166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841110001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0896841110001319"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2010.10.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel autoantibody markers for early and seronegative rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2010.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}